• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library

    Merck, Gilead Update Phase 3 KEYNOTE-D46/EVOKE-03 Study Final

    PRESS RELEASE

    GSK Discusses Acquisition Of Cancer Biotech Nuvalent For Over $9B

    REUTERS

    Lupin Manufacturing Solutions Names Eduardo Jule Chief

    INDPHARMAPOST

    US FDA Approves Pfizer`s Bleeding Disorder Drug For Children

    PRESS RELEASE

    Sanofi Sarclisa Wins EU Nod as First On-Body Injector

    GLOBENEWSWIRE

    RevMed & Tango’s Pancreatic Cancer Combo Achieves 92% Response

    REUTERS

    J&J Bets $1B Upfront on Emerging DAC Space With Firefly Bio

    REUTERS

    Roche Invests $3B In Nurix`s Blood Cancer Protein Degrader

    GLOBENEWSWIRE

    Kunwar Khurana elevated to Head – Sales and Marketing

    INDPHARMAPOST

    Congo Says Ebola Deaths Top 100 As Armed Groups Threaten Response

    REUTERS

    Industry Groups Seek More Flexibility For DHTs In Clinical Trials

    RAPS

    Japan PMDA Issues Guidance on Monoclonal Antibody Toxicity Assess

    RAPS

    NGD Launches NGD200 Automated Bacterial Sample Prep for Hospitals

    ACCESSWIRE

    Ceribell Links Clarity AI Seizure Burden to Neurological Outcomes

    GLOBENEWSWIRE

    Aclarion Rejects Lake Capital’s Unsolicited Acquisition Proposal

    GLOBENEWSWIRE

    Hexiris Ophthalmics Debuts Dry Lab and Milestones at COS Meeting

    GLOBENEWSWIRE

    Hoag Named California`s First Endometriosis Center of Excellence

    GLOBENEWSWIRE

    Vantive Shows HDx as Practical Alternative to Online HDF at ERA

    GLOBENEWSWIRE

    Post-Makary, New Rare Disease Framework Faces Fresh Uncertainty

    BIOSPACE

    Aclarion Shareholders Approve All 2026 Annual Meeting Proposals

    GLOBENEWSWIRE

    Smile Foundation Delivers 20 Lakh Healthcare Treatments In FY26

    INDPHARMAPOST

    Cavalry Biosciences Targets $75M Series B for Eye, Muscle Drugs

    ENDPOINTS

    Sequel Presents twiist AID System Pivotal T2D Trial Data at ADA

    GLOBENEWSWIRE

    ICH Adopts GCP Annex 2, Announces Progress On Other Guidelines

    RAPS

    Vanna Health Names Dr. Liz Kwo CEO, Colella Executive Chairman

    ACCESSWIRE

    CDSCO Seeks State Action Data on Antibiotics Banned in Farming

    PHARMABIZ

    Regentis Starts EU Surgeon Training for GelrinC in Knee Repair

    ACCESSWIRE

    Enovis Launches Spinamic Hybrid Scoliosis Brace for Pediatrics

    GLOBENEWSWIRE

    Busy FDA: Complementary Pathways Despite Unanswered Questions

    BIOSPACE

    Conexeu Reports Manufacturing and Regulatory Progress for CXU

    GLOBENEWSWIRE

    Hyperion Defi Confirms USDH And Felix Markets Sunset Guidance

    GLOBENEWSWIRE

    Lakefront Appoints Eric Hedrick, MD, As Chief Medical Officer

    GLOBENEWSWIRE

    19 Medical Schools Commit to Nutrition Training Requirements

    REUTERS

    Texas Ranchers Doubt USDA Can Contain Flesh-Eating Screwworm

    REUTERS

    Experts to Screen US Wastewater for Disease During World Cup

    REUTERS

    Drug Samples from Major Pharma Companies Fail Quality Tests

    PHARMABIZ

    Ignite Proteomics Launches 10,000-Patient Oncology Registry

    BUSINESSWIRE

    Seek Labs Maps All 25 Viral Families via BioSeeker Platform

    BUSINESSWIRE

    SRx Health Solutions Inc. Acquires 4.99% Stake in Smartkem

    GLOBENEWSWIRE

    Diabetology’s Breakthrough Data From Oraglutide Oral GLP-1

    BUSINESSWIRE

    Adaptyx Shows First In-Human Cortisol Wearable Data at ADA

    BUSINESSWIRE

    ACT-CHIK Launches to Speed Chikungunya Vaccine in Africa

    PRESS RELEASE

    eXoZymes Prices Public Offering of Stock and Warrants

    ACCESSWIRE

    Xealth Appoints Travis Moore As Chief Revenue Officer

    GLOBENEWSWIRE

    Koi Peptides Expands Research Catalog In June 2026

    GLOBENEWSWIRE

    Zevra Therapeutics Lists Patent to Protect MIPLYFFA Exclusivity

    GLOBENEWSWIRE

    Zealand Pharma Drops 25% as Patients Quit Obesity Drug Trial

    REUTERS

    Zealand Pharma Raises Share Capital via Employee Warrant Exercise

    GLOBENEWSWIRE

    Zealand Pharma Executes Share Buy-Back Transactions in Week 23

    GLOBENEWSWIRE

    Zai Lab Gets NMPA Nod for TIVDAK in Cervical Cancer

    BUSINESSWIRE

    WuXi Bio Ireland Wins Top Honor at Life Sciences Awards 2026

    PR NEWSWIRE

    Pentagon Names Biotech Firm Wuxi Apptec To Chinese Military List

    BLOOMBERG

    Vivos Therapeutics to Join Small Cap Showcase on June 9, 2026

    GLOBENEWSWIRE

    Vivoryon Therapeutics to Report Q1 2026 Results on June 11

    GLOBENEWSWIRE

    Alkeus Doses First Patient in Phase 3 Gildeuretinol Study

    GLOBENEWSWIRE

    Virbac Declares Shares & Voting Rights For May 2026

    GLOBENEWSWIRE

    Jorge Di Named EVP and CSO of Versiti Blood Research Institute

    PR NEWSWIRE

    Vaxart Urges Shareholders to Back All Six Director Nominees

    GLOBENEWSWIRE

    Vasa Therapeutics to Present VS-041 Pre-Clinical and Phase 1 Data

    PR NEWSWIRE

    Upstream Bio to Present Verekitug VIBRANT Phase 2 Data at EAACI

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.